Ricardo Vian Marques, General Manager, Galenika

Focus On Quality And Growth Drivers

Despite the challenges of global circumstances in 2023, Galenika successfully ensured the production and distribution of its products to all markets where it operates. It’s priorities for 2024 remain the same: commitment to quality, innovation, portfolio expansion, investments and the further globalisation of its business

Here we discuss the successes and challenges Galenika faced during 2023 and the company’s strategic commitment for the period ahead, as well as global trends in the pharmaceutical industry, with Galenika GM Ricardo Vian Marques.

What would you highlight as the key elements of Galenika’s operations in 2023? What are you satisfied with and what were the challenges?

— The key challenge of the previous year was presented by global circumstances that affected the pharmaceutical industry, among others. We exerted significant efforts and successfully ensured the production and distribution of our high-quality products in Serbia and to the export markets where we operate.

We placed a strategic focus on increasing the portfolio. During 2023, we launched as many as 77 products in Serbia and on the markets of the regions where we operate. In parallel, with the acquisition of Serbian-Slovenian company Lifemedic, we took over the exclusive distribution of the product programme of renowned Italian pharmaceutical company Pharmalife Research for the markets of Serbia, Bosnia and Herzegovina, North Macedonia and Montenegro, and thus launched a partnership with a global company that shares our values. In addition, with our strategic partnership with Brazilian pharmaceutical leader EMS (, during 2023 Galenika successfully realised the transfer of technology for six products from the newer generation of generic drugs.

How do you see the global trends in the pharmaceutical industry and where does Galenika stand?

— Artificial intelligence (AI) and sustainable business (ESG) are gaining ever more representation in the pharmaceutical industry. AI is becoming particularly useful in the drug development process, as it allows pharmaceutical companies to design new molecules, predict their characteristics and optimise new drug candidates faster and more efficiently than traditional methods. I emphasise that it is extremely important that the information is based on relevant data and their relationships, and that it is used in the right way. In addition, in the domain of sustainable business, health equity has emerged as an important trend in the pharmaceutical industry. The focus is on the development of medicines that aren’t only effective, but also available to the wider population. I expect this to be crucial in helping make medicines more accessible to everyone.

We strive to expand our product range with high-quality, latest-generation drugs, which is a prerequisite for us maintaining and achieving even more success. 

Quality is the essential prerequisite of Galenika’s business philosophy and one of the pillars of our sustainable business culture. We have GMP and ISO certificates for quality assurance, while environmental protection and energy efficiency are high on the priority list. We carefully select suppliers in order to ensure the quality of our products. We additionally implement prevention awareness projects, demonstrating corporate responsibility. At the same time, Galenika has invested considerable energy and funds in the digitisation of its operations. State-of-the-art software for detailed production planning, business intelligence and predictive analytics are just some of the innovations that Galenika has introduced over the past six years. In other words, we are focused on drivers of growth and innovation.

What do you expect going forward; what are the company’s priorities?

— Expanding the portfolio remains a key focus as we strive to expand our product range with high-quality, latest-generation drugs, which is a prerequisite for us maintaining and achieving even more success. We are strategically committed to the internationalisation of our business and in 2024 plan to additionally expand our business on the EU and MENA markets. In short, Galenika remains dedicated to and focused on growth through high-quality products, investments, digital transformation, the further globalisation of its business and strategic mergers and acquisitions.

Jelena Puzović, Ph.D., Head of the JVP Srbijavode Public Relations and International Cooperation Sector

Serbia Must Ensure the Conservation of the Precious Resource That is Water

Public Water Management Company Srbijavode engages in numerous activities aimed at overcoming the challenges brought by climate change – implementing projects to develop and...

Uroš Đorđević, Account Executive, Dell Technologies

Pioneer in the New Era of Digital Tech

Dell Technologies is a corporation that’s oriented towards technological innovation and keeps pace with technological trends in every sense, which includes AI Speaking in this...

Ana Toskić Cvetinović, Executive Director, Partners for Democratic Change Serbia

The Rule of Law is Vital Ana

Partners Serbia is an organisation that’s dedicated to advancing the rule of law and developing civil society and institutions in Serbia and around the...

Ioanna Batsialou Ph.D., Director and Owner of the Ioanna Regen Polyclinic

Passion is Key to this Job

Ioanna Batsialou Ph.D. is the director and owner of the Ioanna Regen Polyclinic, which specialises in physical medicine, rehabilitation, mesotherapy, aesthetics and anti-aging treatments Our...

Montenegro’s Independence Day Celebrated

Celebrating Montenegro's Independence Day with an Exhibition on Montenegrin Cyrillic Printing from the 15th and 16th Centuries. In commemoration of...

Business Event Hosts Serbian Employment Service Presentation

In Belgrade on the 15th of May, the Slovenian Business Club, in collaboration with the National Employment Service of...

Launch of the Council of European Business Associations and Chambers in Serbia

European business associations and bilateral chambers have established the Council of European Business Associations and Chambers in Serbia (CEBAC),...

EU Commissioner Várhelyi Visits Serbia to Discuss Deepening Integration and Regional Stability Efforts

In a pivotal meeting in Belgrade, Serbian President Aleksandar Vučić and EU Commissioner for Neighbourhood Policy and Enlargement Olivér...

Ukraine’s First Lady Visits Serbia in Historic Diplomatic Move

Ukraine's First Lady, Olena Zelenska, arrived in Belgrade on Sunday, marking a historic visit as the first top Ukrainian...